User:Jeremy S. Myers: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
|||
| (8 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Contact Info== | ==Contact Info== | ||
[[Image:OWWEmblem.png|thumb|right| | [[Image:OWWEmblem.png|thumb|right|(an artistic interpretation)]] | ||
*Jeremy S. Myers, Ph.D. | *Jeremy S. Myers, Ph.D. | ||
*AstraZeneca Fellow | *AstraZeneca Fellow | ||
*Advanced Targeted Proteomics Team Leader | |||
*Vanderbilt University School of Medicine | *Vanderbilt University School of Medicine | ||
*Mass Spectrometry Research Center | *Mass Spectrometry Research Center | ||
*Nashville, TN, U.S.A. | *Nashville, TN, U.S.A. | ||
* | *jeremy.myers@vanderbilt.edu | ||
for more information visit: http://www.advancedtargetedproteomics.com | |||
==Education== | ==Education== | ||
<!--Include info about your educational background--> | <!--Include info about your educational background--> | ||
* 2003 | * 2003-2007 Postdoctoral Fellow | ||
* 1999 | * 2003 Ph.D., Louisiana State University | ||
* 1999 B.S., Bucknell University | |||
==Research interests== | ==Research interests== | ||
<!-- Feel free to add brief descriptions to your research interests as well --> | <!-- Feel free to add brief descriptions to your research interests as well --> | ||
# | # Targeted Mass Spectrometry-based Proteomics | ||
# | # Targeted Therapeutics | ||
==Publications== | ==Publications (since 2007)== | ||
#Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878 | |||
==Useful links== | ==Useful links== | ||
| Line 31: | Line 30: | ||
*[[Help|OpenWetWare help pages]] | *[[Help|OpenWetWare help pages]] | ||
==Protocols== | ==Selected Protocols== | ||
*[[Myers:EGFR_IP]] | *[[Myers:EGFR_IP]] | ||
*[[Myers:synchronization]] | |||
Latest revision as of 08:20, 14 August 2008
Contact Info
- Jeremy S. Myers, Ph.D.
- AstraZeneca Fellow
- Advanced Targeted Proteomics Team Leader
- Vanderbilt University School of Medicine
- Mass Spectrometry Research Center
- Nashville, TN, U.S.A.
- jeremy.myers@vanderbilt.edu
for more information visit: http://www.advancedtargetedproteomics.com
Education
- 2003-2007 Postdoctoral Fellow
- 2003 Ph.D., Louisiana State University
- 1999 B.S., Bucknell University
Research interests
- Targeted Mass Spectrometry-based Proteomics
- Targeted Therapeutics
Publications (since 2007)
- Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878
